Eugene Fan: Advancing Peripheral Blood Film Analysis with Artificial Intelligence
Eugene Fan, Haematologist at Tan Tock Seng Hospital, Assistant Professor at Lee Kong Chian School of Medicine, shared a post on LinkedIn:
“Some patient journeys – and diagnoses – begin at the microscope.
The peripheral blood film remains one of the most elegant yet simple investigations in Haematology: a stained drop of blood smeared across a glass slide, a trained eye, and sometimes a life-changing diagnosis waiting in plain sight.
Yet behind that simplicity lies a very human challenge. Morphology expertise is variable with our heuristic biases, finite turnaround times, and interpretation and reporting does not always agree across laboratories and healthcare systems.
I am deeply grateful to receive the NMRC Clinician Innovator Award – Senior Investigator to support our work on Artificial Intelligence for the Peripheral Blood Film, and ASUS Blade, an AI-enabled platform for peripheral blood film analysis and telehaematology.
Blade was not conceived as a replacement for the laboratory medical technologist or the haematologist. It was built to support us — to bring greater consistency, speed, explainability, and confidence to haematology labs where morphological expertise is still essential. That means prospective validation, attention to workflow, understanding uncertainty, dealing with edge cases, and failure modes. That means capturing morphology know-how while building tools that allow it to reach further.
This award is an important encouragement — not just for the application of AI in medical images, but for the broader concept that clinician-led innovation has its place in laboratory medicine. The most meaningful innovations often come from the pain points we encounter every day: critical cases that were missed, differences in morphological interpretation between colleagues, and variation in reporting styles that could be made safer, faster, and more accountable.
I am especially grateful to my mentor Ponnudurai Kuperan, colleagues and collaborators, the amazing team from AICS, solid technical expertise from Motic Microscopes (Worldwide), Biodesign training from Singapore Biodesign and the support from Centre for MedTech and Innovations (CMTi) and National Health Innovation Centre (NHIC) that have shaped our work.
Blade is very much a team effort, sitting at the intersection of haematology, computer vision, digital pathology, regulatory governance and clinical implementation.
There is still much to do. But this support gives us the momentum to continue building carefully and confidently — with a clear focus on patient care.
From glass slide to AI algorithm, from morphology to medicine – our work continues.”
Stay updated with Hemostasis Today.
-
May 31, 2026, 11:07Mohamed Al Nasef: A Cohort Analysis of Increased Perioperative Thrombosis Risk in Neonates with TGA
-
May 31, 2026, 10:40Akshat Jain: Pleasure to Present at the Insightful Latin America Hemophilia Meeting
-
May 31, 2026, 10:32Pall T. Onundarson: The 3-Decade Journey of Ultrasound-Enhanced Fibrinolysis in PE
-
May 31, 2026, 10:22La’Ron Browne: Balancing Clinical Benefits and Healthcare Costs in Hydroxyurea Management of SCD in Brazil
-
May 31, 2026, 10:09Purusotham Chippala: A 47-Year-Old Stroke Survivor Taught Me Something Modern Healthcare Keeps Ignoring
-
May 31, 2026, 10:03Mohammed Sakib Hasan: We Propose Innovative AI-Driven Solutions for Real-Time Stroke Prediction
-
May 31, 2026, 09:49Ermias Solomon Yalew: New Insights Into Multimorbidity and Disability After Stroke from Ethiopia
-
May 31, 2026, 07:02Raising Awareness of Cerebral Venous Sinus Thrombosis in Women – NBCA
-
May 31, 2026, 07:00Ceri Roberts: How to Reduce Your Risk of a Blood Clot